{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:10:48Z","timestamp":1792602648005,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T00:00:00Z","timestamp":1707868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A25607, A26978, A26979"],"award-info":[{"award-number":["A25607, A26978, A26979"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["A17196, A2996, A25233"],"award-info":[{"award-number":["A17196, A2996, A25233"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P018920\/1"],"award-info":[{"award-number":["MR\/P018920\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000357","name":"North West Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["102521\/Z\/13\/Z"],"award-info":[{"award-number":["102521\/Z\/13\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pancreatic ductal adenocarcinoma is a highly metastatic disease and macrophages support liver metastases. Efferocytosis, or engulfment of apoptotic cells by macrophages, is an essential process in tissue homeostasis and wound healing, but its role in metastasis is less well understood. Here, we found that the colonization of the hepatic metastatic site is accompanied by low-grade tissue injury and that efferocytosis-mediated clearance of parenchymal dead cells promotes macrophage reprogramming and liver metastasis. Mechanistically, progranulin expression in macrophages is necessary for efficient efferocytosis by controlling lysosomal acidification via cystic fibrosis transmembrane conductance regulator and the degradation of lysosomal cargo, resulting in LXR\u03b1\/RXR\u03b1-mediated macrophage conversion and upregulation of arginase 1. Pharmacological blockade of efferocytosis or macrophage-specific genetic depletion of progranulin impairs macrophage conversion, improves CD8<jats:sup>+<\/jats:sup> T cell functions, and reduces liver metastasis. Our findings reveal how hard-wired functions of macrophages in tissue repair contribute to liver metastasis and identify potential targets for prevention of pancreatic ductal adenocarcinoma liver metastasis.<\/jats:p>","DOI":"10.1038\/s43018-024-00731-2","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T11:02:24Z","timestamp":1707908544000},"page":"774-790","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis"],"prefix":"10.1038","volume":"5","author":[{"given":"Yuliana","family":"Astuti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meirion","family":"Raymant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Quaranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maidinaimu","family":"Abudula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vatshala","family":"Chandran-Gorner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Nourse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Halloran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Ghaneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4579-0053","authenticated-orcid":false,"given":"Jeffrey W.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5766-9141","authenticated-orcid":false,"given":"Jennifer P.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainhoa","family":"Mielgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3445-0013","authenticated-orcid":false,"given":"Michael C.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,14]]},"reference":[{"key":"731_CR1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani, C. et al. Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391, 1023\u20131075 (2018).","journal-title":"Lancet"},{"key":"731_CR2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","volume":"371","author":"DP Ryan","year":"2014","unstructured":"Ryan, D. P., Hong, T. S. & Bardeesy, N. Pancreatic adenocarcinoma. N. Engl. J. Med. 371, 1039\u20131049 (2014).","journal-title":"N. Engl. J. Med."},{"key":"731_CR3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","volume":"378","author":"A Vincent","year":"2011","unstructured":"Vincent, A., Herman, J., Schulick, R., Hruban, R. H. & Goggins, M. Pancreatic cancer. Lancet 378, 607\u2013620 (2011).","journal-title":"Lancet"},{"key":"731_CR4","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","volume":"379","author":"T Conroy","year":"2018","unstructured":"Conroy, T. et al. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N. Engl. J. Med. 379, 2395\u20132406 (2018).","journal-title":"N. Engl. J. Med."},{"key":"731_CR5","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","volume":"20","author":"AC Doran","year":"2020","unstructured":"Doran, A. C. Efferocytosis in health and disease. Nat. Rev. Immunol. 20, 254\u2013267 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"731_CR6","first-page":"398","volume":"21","author":"DR Green","year":"2020","unstructured":"Green, D. R. The clearance of dead cells by efferocytosis. Nat. Rev. Mol. Cell Biol. 21, 398\u2013414 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"731_CR7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo, D. G. & Ruffell, B. Macrophages as regulators of tumour immunity and immunotherapy. Nat. Rev. Immunol. 19, 369\u2013382 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"731_CR8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nri3789","volume":"15","author":"T Kitamura","year":"2015","unstructured":"Kitamura, T., Qian, B.-Z. & Pollard, J. W. Immune cell promotion of metastasis. Nat. Rev. Immunol. 15, 73\u201386 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"731_CR9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/ncb3340","volume":"18","author":"SR Nielsen","year":"2016","unstructured":"Nielsen, S. R. et al. Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis. Nat. Cell Biol. 18, 549\u2013560 (2016).","journal-title":"Nat. Cell Biol."},{"key":"731_CR10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-021-00261-6","volume":"7","author":"DI Tsilimigras","year":"2021","unstructured":"Tsilimigras, D. I. et al. Liver metastases. Nat. Rev. Dis. Prim. 7, 27 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"731_CR11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.trecan.2018.03.011","volume":"4","author":"GR Doak","year":"2018","unstructured":"Doak, G. R., Schwertfeger, K. L. & Wood, D. K. Distant relations: macrophage functions in the metastatic niche. Trends Cancer 4, 445\u2013459 (2018).","journal-title":"Trends Cancer"},{"key":"731_CR12","doi-asserted-by":"crossref","first-page":"9624760","DOI":"10.1155\/2017\/9624760","volume":"2017","author":"SR Nielsen","year":"2017","unstructured":"Nielsen, S. R. & Schmid, M. C. Macrophages as key drivers of cancer progression and metastasis. Mediators Inflamm. 2017, 9624760 (2017).","journal-title":"Mediators Inflamm."},{"key":"731_CR13","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani, A., Allavena, P., Marchesi, F. & Garlanda, C. Macrophages as tools and targets in cancer therapy. Nat. Rev. Drug Discov. 21, 799\u2013820 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"731_CR14","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","volume":"43","author":"R-Y Ma","year":"2022","unstructured":"Ma, R.-Y., Black, A. & Qian, B.-Z. Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol. 43, 546\u2013563 (2022).","journal-title":"Trends Immunol."},{"key":"731_CR15","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1158\/0008-5472.CAN-17-3876","volume":"78","author":"V Quaranta","year":"2018","unstructured":"Quaranta, V. et al. Macrophage-derived granulin drives resistance to immune checkpoint inhibition in metastatic pancreatic cancer. Cancer Res. 78, 4253\u20134269 (2018).","journal-title":"Cancer Res."},{"key":"731_CR16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","volume":"18","author":"Y Wen","year":"2021","unstructured":"Wen, Y. Hepatic macrophages in liver homeostasis and diseases- diversity, plasticity and therapeutic opportunities. Cell. Mol. Immunol. 18, 45\u201356 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"731_CR17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","volume":"185","author":"M Guilliams","year":"2022","unstructured":"Guilliams, M. et al. Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches. Cell 185, 379\u2013396 (2022).","journal-title":"Cell"},{"key":"731_CR18","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri3070","volume":"11","author":"C Shi","year":"2011","unstructured":"Shi, C. & Pamer, E. G. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11, 762\u2013774 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"731_CR19","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1053\/j.gastro.2017.01.021","volume":"152","author":"KKY Lai","year":"2017","unstructured":"Lai, K. K. Y. et al. Stearoyl-CoA desaturase promotes liver fibrosis and tumor development in mice via a Wnt positive-signaling loop by stabilization of low-density lipoprotein-receptor-related proteins 5 and 6. Gastroenterology 152, 1477\u20131491 (2017).","journal-title":"Gastroenterology"},{"key":"731_CR20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","volume":"16","author":"K Kazankov","year":"2019","unstructured":"Kazankov, K. et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat. Rev. Gastroenterol. Hepatol. 16, 145\u2013159 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"731_CR21","doi-asserted-by":"crossref","first-page":"110609","DOI":"10.1016\/j.celrep.2022.110609","volume":"39","author":"S Li","year":"2022","unstructured":"Li, S. et al. Metabolism drives macrophage heterogeneity in the tumor microenvironment. Cell Rep. 39, 110609 (2022).","journal-title":"Cell Rep."},{"key":"731_CR22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1084\/jem.20122006","volume":"210","author":"SZ Ben-Sasson","year":"2013","unstructured":"Ben-Sasson, S. Z. et al. IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells. J. Exp. Med. 210, 491\u2013502 (2013).","journal-title":"J. Exp. Med."},{"key":"731_CR23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2016.08.003","volume":"101","author":"AK Mehta","year":"2018","unstructured":"Mehta, A. K., Gracias, D. T. & Croft, M. TNF activity and T cells. Cytokine 101, 14\u201318 (2018).","journal-title":"Cytokine"},{"key":"731_CR24","doi-asserted-by":"crossref","first-page":"e131355","DOI":"10.1172\/jci.insight.131355","volume":"4","author":"W Cai","year":"2019","unstructured":"Cai, W. et al. STAT6\/Arg1 promotes microglia\/macrophage efferocytosis and inflammation resolution in stroke mice. JCI Insight 4, e131355 (2019).","journal-title":"JCI Insight"},{"key":"731_CR25","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.cmet.2020.01.001","volume":"31","author":"AJ Yurdagul","year":"2020","unstructured":"Yurdagul, A. J. et al. Macrophage metabolism of apoptotic cell-derived arginine promotes continual efferocytosis and resolution of injury. Cell Metab. 31, 518\u2013533 (2020).","journal-title":"Cell Metab."},{"key":"731_CR26","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.1158\/0008-5472.CAN-04-0972","volume":"64","author":"Y-M Wu","year":"2004","unstructured":"Wu, Y.-M., Robinson, D. R. & Kung, H.-J. Signal pathways in up-regulation of chemokines by tyrosine kinase MER\/NYK in prostate cancer cells. Cancer Res. 64, 7311\u20137320 (2004).","journal-title":"Cancer Res."},{"key":"731_CR27","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1038\/onc.2012.355","volume":"32","author":"RMA Linger","year":"2013","unstructured":"Linger, R. M. A. et al. Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer. Oncogene 32, 3420\u20133431 (2013).","journal-title":"Oncogene"},{"key":"731_CR28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrc3847","volume":"14","author":"DK Graham","year":"2014","unstructured":"Graham, D. K., Deryckere, D., Davies, K. D. & Earp, H. S. The TAM family: phosphatidylserine-sensing receptor tyrosine kinases gone awry in cancer. Nat. Rev. Cancer 14, 769\u2013785 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"731_CR29","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.immuni.2020.01.014","volume":"52","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Blockade of the phagocytic receptor MerTK on tumor-associated macrophages enhances P2X7R-dependent STING activation by tumor-derived cGAMP. Immunity 52, 357\u2013373 (2020).","journal-title":"Immunity"},{"key":"731_CR30","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1016\/j.ajpath.2014.07.019","volume":"184","author":"B Bhushan","year":"2014","unstructured":"Bhushan, B. et al. Pro-regenerative signaling after acetaminophen-induced acute liver injury in mice identified using a novel incremental dose model. Am. J. Pathol. 184, 3013\u20133025 (2014).","journal-title":"Am. J. Pathol."},{"key":"731_CR31","doi-asserted-by":"crossref","first-page":"e0243451","DOI":"10.1371\/journal.pone.0243451","volume":"15","author":"P Adhyapok","year":"2021","unstructured":"Adhyapok, P. et al. A computational model of liver tissue damage and repair. PLoS ONE 15, e0243451 (2021).","journal-title":"PLoS ONE"},{"key":"731_CR32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrn.2017.36","volume":"18","author":"AW Kao","year":"2017","unstructured":"Kao, A. W., McKay, A., Singh, P. P., Brunet, A. & Huang, E. J. Progranulin, lysosomal regulation and neurodegenerative disease. Nat. Rev. Neurosci. 18, 325\u2013333 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"731_CR33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1084\/jem.20091568","volume":"207","author":"F Yin","year":"2010","unstructured":"Yin, F. et al. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J. Exp. Med. 207, 117\u2013128 (2010).","journal-title":"J. Exp. Med."},{"key":"731_CR34","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neuron.2010.09.034","volume":"68","author":"F Hu","year":"2010","unstructured":"Hu, F. et al. Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron 68, 654\u2013667 (2010).","journal-title":"Neuron"},{"key":"731_CR35","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1084\/jem.20160999","volume":"214","author":"MC Chang","year":"2017","unstructured":"Chang, M. C. et al. Progranulin deficiency causes impairment of autophagy and TDP-43 accumulation. J. Exp. Med. 214, 2611\u20132628 (2017).","journal-title":"J. Exp. Med."},{"key":"731_CR36","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.cmet.2021.08.001","volume":"33","author":"A Trzeciak","year":"2021","unstructured":"Trzeciak, A., Wang, Y.-T. & Perry, J. S. A. First we eat, then we do everything else: The dynamic metabolic regulation of efferocytosis. Cell Metab. 33, 2126\u20132141 (2021).","journal-title":"Cell Metab."},{"key":"731_CR37","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.atherosclerosis.2010.08.006","volume":"213","author":"B Pourcet","year":"2010","unstructured":"Pourcet, B. & Pineda-Torra, I. LXR activation induces arginase 1 expression in macrophages. Atherosclerosis 213, e7 (2010).","journal-title":"Atherosclerosis"},{"key":"731_CR38","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1126\/science.289.5484.1524","volume":"289","author":"JJ Repa","year":"2000","unstructured":"Repa, J. J. et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289, 1524\u20131529 (2000).","journal-title":"Science"},{"key":"731_CR39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cell.2018.08.061","volume":"175","author":"LD Cunha","year":"2018","unstructured":"Cunha, L. D. et al. LC3-associated phagocytosis in myeloid cells promotes tumor immune tolerance. Cell 175, 429\u2013441 (2018).","journal-title":"Cell"},{"key":"731_CR40","doi-asserted-by":"crossref","first-page":"819554","DOI":"10.3389\/fcimb.2022.819554","volume":"12","author":"JS Lee","year":"2022","unstructured":"Lee, J. S., Badr, A., Eltobgy, M., Krause, K. & Hamilton, K. CFTR modulators restore acidification of autophago-lysosomes and bacterial clearance in cystic fibrosis macrophages. Front. Cell Infect. Microbiol. 12, 819554 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"731_CR41","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ncb1456","volume":"8","author":"A Di","year":"2006","unstructured":"Di, A. et al. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat. Cell Biol. 8, 933\u2013944 (2006).","journal-title":"Nat. Cell Biol."},{"key":"731_CR42","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng, S. et al. A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184, 792\u2013809 (2021).","journal-title":"Cell"},{"key":"731_CR43","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","volume":"50","author":"R Zilionis","year":"2019","unstructured":"Zilionis, R. et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity 50, 1317\u20131334 (2019).","journal-title":"Immunity"},{"key":"731_CR44","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/j.immuni.2021.07.007","volume":"54","author":"K Mulder","year":"2021","unstructured":"Mulder, K. et al. Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease. Immunity 54, 1883\u20131900 (2021).","journal-title":"Immunity"},{"key":"731_CR45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.immuni.2017.07.014","volume":"47","author":"Y Zhu","year":"2017","unstructured":"Zhu, Y. et al. Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression. Immunity 47, 323\u2013338 (2017).","journal-title":"Immunity"},{"key":"731_CR46","doi-asserted-by":"crossref","first-page":"631714","DOI":"10.3389\/fimmu.2021.631714","volume":"12","author":"C Yin","year":"2021","unstructured":"Yin, C. & Heit, B. Cellular responses to the efferocytosis of apoptotic cells. Front. Immunol. 12, 631714 (2021).","journal-title":"Front. Immunol."},{"key":"731_CR47","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.immuni.2017.10.006","volume":"47","author":"AW Roberts","year":"2017","unstructured":"Roberts, A. W. et al. Tissue-resident macrophages are locally programmed for silent clearance of apoptotic cells. Immunity 47, 913\u2013927 (2017).","journal-title":"Immunity"},{"key":"731_CR48","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1172\/JCI67655","volume":"123","author":"RS Cook","year":"2013","unstructured":"Cook, R. S. et al. MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis. J. Clin. Invest. 123, 3231\u20133242 (2013).","journal-title":"J. Clin. Invest."},{"key":"731_CR49","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1158\/1078-0432.CCR-19-0795","volume":"25","author":"MS Caetano","year":"2019","unstructured":"Caetano, M. S. et al. Triple therapy with MerTK and PD1 inhibition plus radiotherapy promotes abscopal antitumor immune responses. Clin. Cancer Res. 25, 7576\u20137584 (2019).","journal-title":"Clin. Cancer Res."},{"key":"731_CR50","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1158\/0008-5472.CAN-20-2066","volume":"81","author":"V Davra","year":"2021","unstructured":"Davra, V. et al. Axl and mertk receptors cooperate to promote breast cancer progression by combined oncogenic signaling and evasion of host antitumor immunity. Cancer Res. 81, 698\u2013712 (2021).","journal-title":"Cancer Res."},{"key":"731_CR51","doi-asserted-by":"crossref","first-page":"100324","DOI":"10.1016\/j.jhepr.2021.100324","volume":"3","author":"R Chen","year":"2021","unstructured":"Chen, R., Du, J., Zhu, H. & Ling, Q. The role of cGAS-STING signalling in liver diseases. JHEP Rep. Innov. Hepatol. 3, 100324 (2021).","journal-title":"JHEP Rep. Innov. Hepatol."},{"key":"731_CR52","doi-asserted-by":"crossref","first-page":"e004584","DOI":"10.1136\/jitc-2022-004584","volume":"10","author":"G Marelli","year":"2022","unstructured":"Marelli, G. et al. Lipid-loaded macrophages as new therapeutic target in cancer. J. Immunother. Cancer 10, e004584 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"731_CR53","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.2147\/JIR.S339254","volume":"14","author":"Y-J Lan","year":"2021","unstructured":"Lan, Y.-J., Sam, N. B., Cheng, M.-H., Pan, H.-F. & Gao, J. Progranulin as a potential therapeutic target in immune-mediated diseases. J. Inflamm. Res. 14, 6543\u20136556 (2021).","journal-title":"J. Inflamm. Res."},{"key":"731_CR54","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","volume":"324","author":"KP Olive","year":"2009","unstructured":"Olive, K. P. et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324, 1457\u20131461 (2009).","journal-title":"Science"},{"key":"731_CR55","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","volume":"7","author":"SR Hingorani","year":"2005","unstructured":"Hingorani, S. R. et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7, 469\u2013483 (2005).","journal-title":"Cancer Cell"},{"key":"731_CR56","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","volume":"160","author":"SF Boj","year":"2015","unstructured":"Boj, S. F. et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324\u2013338 (2015).","journal-title":"Cell"},{"key":"731_CR57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/978-1-62703-764-8_16","volume":"1116","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y., Werling, U. & Edelmann, W. Seamless ligation cloning extract (SLiCE) cloning method. Methods Mol. Biol. 1116, 235\u2013244 (2014).","journal-title":"Methods Mol. Biol."},{"key":"731_CR58","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nprot.2015.017","volume":"10","author":"I Mederacke","year":"2015","unstructured":"Mederacke, I., Dapito, D. H., Aff\u00f2, S., Uchinami, H. & Schwabe, R. F. High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nat. Protoc. 10, 305\u2013315 (2015).","journal-title":"Nat. Protoc."}],"updated-by":[{"DOI":"10.1038\/s43018-024-00751-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000}}],"container-title":["Nature Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43018-024-00731-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-024-00731-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43018-024-00731-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T23:03:20Z","timestamp":1717023800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43018-024-00731-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,14]]},"references-count":58,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["731"],"URL":"https:\/\/doi.org\/10.1038\/s43018-024-00731-2","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s43018-024-00751-y","asserted-by":"object"}]},"ISSN":["2662-1347"],"issn-type":[{"value":"2662-1347","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,14]]},"assertion":[{"value":"24 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s43018-024-00751-y","URL":"https:\/\/doi.org\/10.1038\/s43018-024-00751-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}